A pilot study of treatment of social phobia with alprazolam

Am J Psychiatry. 1988 May;145(5):590-4. doi: 10.1176/ajp.145.5.590.

Abstract

Fourteen patients with DSM-III social phobia were treated with alprazolam in an open study. Multiple measures of symptoms and disability showed significant improvement. The symptoms improved during the first and second weeks, and disability improved at 3 weeks and beyond. After medication withdrawal the symptom and disability measures were no longer significantly different from those at baseline.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alprazolam / therapeutic use*
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Middle Aged
  • Personality Disorders / drug therapy
  • Personality Disorders / psychology
  • Personality Inventory
  • Phobic Disorders / drug therapy*
  • Phobic Disorders / psychology
  • Pilot Projects
  • Psychiatric Status Rating Scales
  • Time Factors

Substances

  • Alprazolam